Načítá se...
A Whole Blood Assay for AR-V7 and AR(v567es) in Prostate Cancer Patients
PURPOSE: The majority of prostate cancer mortality can be attributed to metastatic castration-resistant prostate cancer, an advanced stage which remains incurable despite recent advances. The androgen receptor (AR) signaling axis remains active in CRPC. Recent studies suggest that the expression of...
Uloženo v:
| Vydáno v: | J Urol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161406/ https://ncbi.nlm.nih.gov/pubmed/27449259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2016.06.095 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|